• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估爱沙尼亚献血者中戊型肝炎临床标志物的流行情况。

Evaluation of Prevalence of Hepatitis E Clinical Markers among Donors in Estonia.

机构信息

Department of Infectious Disease Research, National Institute for Health Development, 11619 Tallinn, Estonia.

North Estonia Medical Centre's Blood Center, North Estonia Medical Centre Foundation, 13419 Tallinn, Estonia.

出版信息

Viruses. 2023 Oct 19;15(10):2118. doi: 10.3390/v15102118.

DOI:10.3390/v15102118
PMID:37896895
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10612021/
Abstract

Hepatitis E virus (HEV) is now considered the most common cause of acute hepatitis worldwide. There are no published data about the prevalence of antibodies to HEV and RNA in donor sera in Estonia, and this precludes planning measures for preventing HEV proliferation through blood transfusion services. Here, were report data from an analysis of 1002 sera on the prevalence of anti-HEV IgG and IgM and the viral RNA. The antibodies were found in 48 donor sera (4.8%); of these, 40 (4%) harbored anti-HEV IgG, 15 (1.5%) contained anti-HEV IgM, and 7 donors had anti-HEV antibodies of both classes simultaneously. HEV RNA was not detected in any blood serum. Statistical associations of infection risk factors (gender, age, travel in the last six months, contact with pigs and/or wild boars in the last six months, consumption of thermally unprocessed/raw pork or boar meat, raw/unfiltered tap water or water from natural sources, unpasteurized farm dairy products, and unwashed berries and/or vegetables) were assessed. None of the listed factors were found to be associated with a higher or lower risk of anti-HEV antibody presence. At the same time, an increasing share of anti-HEV IgG carriers with age was found. The absence of HEV RNA in the analyzed donor plasma samples proves that HEV acute infection prevalence in Estonia does not exceed the average level of European countries. There is no urgent necessity to enter a requirement for a total screening of blood plasma for HEV RNA prevalence in Estonia.

摘要

戊型肝炎病毒(HEV)现已被认为是全球范围内最常见的急性肝炎病因。目前,在爱沙尼亚尚无关于供体血清中抗 HEV 抗体和 RNA 流行率的相关数据,这使得通过输血服务预防 HEV 传播的措施无法得到规划。在此,我们报告了对 1002 份血清进行的抗 HEV IgG 和 IgM 以及病毒 RNA 分析的数据。在 48 份供体血清中发现了这些抗体(4.8%);其中,40 份(4%)含有抗 HEV IgG,15 份(1.5%)含有抗 HEV IgM,7 份供体同时具有两种类型的抗 HEV 抗体。在任何血清中均未检测到 HEV RNA。我们评估了感染危险因素(性别、年龄、过去六个月内的旅行、过去六个月内与猪和/或野猪的接触、食用未经热处理/生猪肉或野猪肉、未经处理的自来水或天然水源水、未经巴氏消毒的农场奶制品以及未经清洗的浆果和/或蔬菜)与感染风险之间的统计学关联。列表中的任何因素都与抗 HEV 抗体存在的更高或更低风险无关。与此同时,我们发现抗 HEV IgG 携带者的比例随着年龄的增长而增加。分析的供体血浆样本中未检测到 HEV RNA,这证明 HEV 急性感染在爱沙尼亚的流行率并未超过欧洲国家的平均水平。因此,在爱沙尼亚,目前尚无必要对血浆进行 HEV RNA 流行率的全面筛查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f76/10612021/667b89fca1d1/viruses-15-02118-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f76/10612021/667b89fca1d1/viruses-15-02118-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f76/10612021/667b89fca1d1/viruses-15-02118-g001.jpg

相似文献

1
Evaluation of Prevalence of Hepatitis E Clinical Markers among Donors in Estonia.评估爱沙尼亚献血者中戊型肝炎临床标志物的流行情况。
Viruses. 2023 Oct 19;15(10):2118. doi: 10.3390/v15102118.
2
Hepatitis E virus infection in different groups of Estonian patients and people who inject drugs.在不同组别爱沙尼亚患者和注射吸毒者中的戊型肝炎病毒感染。
J Clin Virol. 2018 Jul;104:5-10. doi: 10.1016/j.jcv.2018.04.011. Epub 2018 Apr 20.
3
Hepatitis E Virus in Domestic Pigs, Wild Boars, Pig Farm Workers, and Hunters in Estonia.爱沙尼亚家猪、野猪、养猪场工人及猎人中的戊型肝炎病毒
Food Environ Virol. 2015 Dec;7(4):403-12. doi: 10.1007/s12560-015-9210-8. Epub 2015 Jul 4.
4
High Hepatitis E Virus (HEV) Seroprevalence and No Evidence of HEV Viraemia in Vietnamese Blood Donors.越南献血者中高戊型肝炎病毒(HEV)血清流行率和无 HEV 病毒血症证据。
Viruses. 2023 Oct 11;15(10):2075. doi: 10.3390/v15102075.
5
High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014.2014 年 2 月至 3 月,意大利中部献血者中抗戊型肝炎病毒抗体的高流行率。
Euro Surveill. 2016 Jul 28;21(30). doi: 10.2807/1560-7917.ES.2016.21.30.30299.
6
Prevalence and risk factors for hepatitis E virus infection in blood donors: a nationwide survey in Italy, 2017 to 2019.2017 年至 2019 年意大利全国献血者中戊型肝炎病毒感染的流行情况和危险因素调查。
Euro Surveill. 2022 Jun;27(22). doi: 10.2807/1560-7917.ES.2022.27.22.2100516.
7
Detection and characterization of hepatitis E virus genotype 3 in HIV-infected patients and blood donors from southern Brazil.检测和鉴定来自巴西南部的 HIV 感染患者和献血者中的戊型肝炎病毒 3 基因型。
Int J Infect Dis. 2019 Sep;86:114-121. doi: 10.1016/j.ijid.2019.06.027. Epub 2019 Jul 4.
8
Seroprevalence of hepatitis E virus among blood donors in eastern Algeria.阿尔及利亚东部献血者中戊型肝炎病毒的血清流行率。
Trop Doct. 2022 Oct;52(4):479-483. doi: 10.1177/00494755221112212. Epub 2022 Jul 6.
9
Risk of hepatitis-E virus infections among blood donors in a regional blood transfusion centre in western India.在印度西部一个地区血液中心的献血者中戊型肝炎病毒感染的风险。
Transfus Med. 2021 Jun;31(3):193-199. doi: 10.1111/tme.12760. Epub 2021 Mar 18.
10
Seroprevalence of hepatitis E virus (HEV) in humans living in high pig density areas of Germany.德国生猪高密度养殖地区人群中戊型肝炎病毒(HEV)的血清流行率。
Med Microbiol Immunol. 2014 Aug;203(4):273-82. doi: 10.1007/s00430-014-0336-3. Epub 2014 Apr 18.

引用本文的文献

1
Hepatitis E Virus Infection in Voluntary Blood Donors in the Russian Federation.俄罗斯联邦无偿献血者中的戊型肝炎病毒感染
Viruses. 2024 Mar 28;16(4):526. doi: 10.3390/v16040526.

本文引用的文献

1
Detection of Hepatitis A RNA, Hepatitis E RNA, Human Adenovirus F DNA, and Norovirus RNA in Fresh and Frozen Berry Products at Point of Retail in Ireland.在爱尔兰零售点检测新鲜和冷冻浆果产品中的甲型肝炎 RNA、戊型肝炎 RNA、人腺病毒 F DNA 和诺如病毒 RNA。
Food Environ Virol. 2023 Sep;15(3):246-254. doi: 10.1007/s12560-023-09561-4. Epub 2023 Aug 1.
2
Hepatitis E Virus in Finland: Epidemiology and Risk in Blood Donors and in the General Population.芬兰的戊型肝炎病毒:献血者及普通人群中的流行病学与风险
Pathogens. 2023 Mar 18;12(3):484. doi: 10.3390/pathogens12030484.
3
Higher Risk of HEV Transmission and Exposure among Blood Donors in Europe and Asia in Comparison to North America: A Meta-Analysis.
与北美相比,欧洲和亚洲献血者中戊型肝炎病毒传播和暴露的风险更高:一项荟萃分析。
Pathogens. 2023 Mar 8;12(3):425. doi: 10.3390/pathogens12030425.
4
Prevalence of HEV infection in acute non-ABC hepatitis and prognostic role of extrahepatic manifestations.戊型肝炎病毒感染在急性非ABC型肝炎中的患病率及肝外表现的预后作用。
Infez Med. 2023 Mar 1;31(1):70-78. doi: 10.53854/liim-3101-10. eCollection 2022.
5
Geographic and Temporal Variability of Hepatitis E Virus Circulation in the Russian Federation.俄罗斯联邦戊型肝炎病毒传播的地域和时间差异。
Viruses. 2022 Dec 22;15(1):37. doi: 10.3390/v15010037.
6
Molecular Characterization and Seroprevalence of Hepatitis E Virus in Inflammatory Bowel Disease Patients and Solid Organ Transplant Recipients.炎症性肠病患者和实体器官移植受者中戊型肝炎病毒的分子特征和血清流行率。
Viruses. 2021 Apr 13;13(4):670. doi: 10.3390/v13040670.
7
Hepatitis E virus and blood transfusion safety.戊型肝炎病毒与输血安全。
Epidemiol Infect. 2020 Jun 29;148:e158. doi: 10.1017/S0950268820001429.
8
Seroprevalence Study of Anti-HEV IgG among Different Adult Populations in Corsica, France, 2019.2019年法国科西嘉岛不同成年人群中抗戊型肝炎病毒IgG血清流行率研究
Microorganisms. 2019 Oct 16;7(10):460. doi: 10.3390/microorganisms7100460.
9
Epidemiology of hepatitis E in South-East Europe in the "One Health" concept.东南欧“同一健康”概念下戊型肝炎的流行病学。
World J Gastroenterol. 2019 Jul 7;25(25):3168-3182. doi: 10.3748/wjg.v25.i25.3168.
10
Blood Donor Screening for Hepatitis E Virus in the European Union.欧盟戊型肝炎病毒献血者筛查
Transfus Med Hemother. 2019 Apr;46(2):95-103. doi: 10.1159/000499121. Epub 2019 Mar 14.